PMID: 3753059Sep 1, 1986Paper

Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF)

Annals of Surgery
D R KnightonE L Butler

Abstract

Previous animal data showed that platelets contain growth factors that stimulate capillary endothelial migration (angiogenesis), fibroblast proliferation and migration, and collagen synthesis. This study utilized autologous platelet-derived wound healing factors (PDWHF) to treat 49 patients with chronic nonhealing cutaneous ulcers. Patients were classified on the basis of 20 clinical and wound status parameters to generate a wound severity index. Forty-nine patients--58% diabetic (20% with renal transplants); 16% with trauma, vasculitis, etc.; 14% with decubitus ulcers; and 6% each with venous stasis or arterial insufficiency--with a total of 95 wounds had received conventional wound care for an average of 198 weeks (range: 1-1820 weeks). After informed consent was obtained, patients received autologous PDWHF. Mean 100% healing time for all patients was 10.6 weeks. There was no abnormal tissue formation, keloid, or hypertrophic scarring. A multivariant analysis showed a direct correlation to 100% healing with initial wound size and the initiation of PDWHF therapy. This is the first clinical demonstration that locally acting growth factors promote healing of chronic cutaneous ulcers.

References

Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H N AntoniadesC D Stiles
Dec 1, 1985·The Journal of Clinical Investigation·G R GrotendorstA K Harvey
Apr 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·R RossL Harker
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M J BandaZ Werb

❮ Previous
Next ❯

Citations

Jan 19, 1990·Klinische Wochenschrift·A J HabenichtG Schettler
Nov 1, 1996·The Histochemical Journal·D A WalshT P Fan
Jul 28, 2011·Rheumatology International·Dilia GiuggioliClodoveo Ferri
Mar 20, 2003·Current Diabetes Reports·Matthew J ClaxtonAndrew J M Boulton
Jun 1, 1995·British Journal of Plastic Surgery·S E CrossT C Teo
Jan 1, 1992·Biomaterials·A KishidaT Matsuda
Dec 1, 1991·Pharmacology & Therapeutics·F Arnold, D C West
Feb 1, 1996·Burns : Journal of the International Society for Burn Injuries·H J WangD M Chang
Jan 1, 1993·Brain Research Bulletin·Y HiraizumiV D Fiegel
Apr 6, 2004·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Giovanni CrovettiAngelo Carabelli
Mar 15, 2003·Clinics in Plastic Surgery·David G Greenhalgh
Sep 23, 1997·Biomaterials·M E Nimni
Jan 1, 1988·Collagen and Related Research·J M McPhersonR A Clark
Mar 1, 1991·Journal of the American College of Cardiology·J S ForresterJ Fagin
Dec 20, 2002·Clinics in Dermatology·Andreas Katsambas, Panagiota Riga
Jan 13, 2000·Clinics in Dermatology·N TsankovJ Kazandjieva
Mar 17, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·S O OyiboA J Boulton
Apr 12, 2000·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·N J TrengoveM C Stacey
Jul 13, 1989·The New England Journal of Medicine·G L BrownJ B Lynch
Jan 1, 1996·The Journal of Cell Biology·J Xu, R A Clark
Nov 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin A LipskyMichael Zasloff
Dec 1, 1988·Annals of Surgery·G L BrownG S Schultz
Mar 26, 1998·Plastic and Reconstructive Surgery·D M Green, B Klink
Jan 31, 2002·Plastic and Reconstructive Surgery·Peter A BlumeChristopher E Attinger
Mar 3, 2010·Plastic and Reconstructive Surgery·Seong-Ho JeongWoo-Kyung Kim
Jun 3, 2010·Plastic and Reconstructive Surgery·Jeffrey E JanisDonald H Lalonde
Nov 1, 1990·Clinical and Experimental Dermatology·M ConyA Taïeb
Jan 1, 1992·Journal of the National Medical Association·M L Walker
Mar 1, 1993·International Journal of Dermatology·A K PendseS Hada
Jan 1, 1995·Annual Review of Medicine·G F Pierce, T A Mustoe
Sep 1, 1994·Journal of Endovascular Surgery : the Official Journal of the International Society for Endovascular Surgery·J R Crew, M Thuener
Mar 1, 2000·Journal of Periodontology·S J MerawT M Sioussat
Jun 10, 2010·Nanomedicine·Roberta CortivoBarbara Zavan
Nov 30, 2012·Techniques in Coloproctology·A KucharczykK Bielecki
Jul 12, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Dariusz WaniczekEwa Nowakowska-Zajdel
Jan 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Janka KisuckaDenisa D Wagner
May 24, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin A Lipsky Infectious Diseases Society of America
Nov 15, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Vincenzo IervolinoCarmela Cacciapuoti
May 24, 2011·Stem Cells International·Chandana TekkatteKavitha Sankaranarayanan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.